Table 2c.
Percent inhibition data for positive control inhibitors.
| Isoforms | CYP1A2 | CYP2C8 | CYP2C9 | CYP2C19 | CYP2D6 | CYP3A41 | CYP3A42 |
|---|---|---|---|---|---|---|---|
| Concentration tested | 20 nM | 25 µM | 1 µM | 2 µM | 100 nM | 50 nM | 50 nM |
| α-Nepthoflavone | 62.43 | - | - | - | - | - | - |
| Ticlopidine | - | - | - | - | - | - | |
| Rosiglitazone | - | 69.23 | - | - | - | - | |
| Sulfaphenazole | - | - | 83.87 | - | - | - | |
| Ticlopidine | - | - | - | 71.03 | - | - | |
| Quinidine | - | - | - | - | 67.43 | - | |
| Ketoconazole | - | - | - | - | - | 69.17 | |
| Ketoconazole | - | - | - | - | - | - | 80.06 |
CYP: Cytochrome P450, 1: Testosterone was used as substrate, 2: Midazolam was used as substrate, (-): Not applicable.